Ligand validation:1PS3

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1PS3_MRD_A_1602	49%	82%	0.132	0.879	0.52	0.28	-	-	2	0	100%	1
3DDF_MRD_A_5001	79%	48%	0.087	0.931	0.67	1.33	-	1	3	0	100%	1
2OW6_MRD_A_5001	74%	44%	0.095	0.925	0.75	1.39	-	2	3	0	100%	1
1HWW_MRD_A_1104	61%	16%	0.126	0.914	1.17	2.47	1	3	3	0	100%	1
1SWU_MRD_A_1	97%	67%	0.05	0.967	0.44	0.83	-	1	0	0	100%	1
7EK9_MRD_A_201	97%	88%	0.06	0.977	0.29	0.38	-	-	0	0	100%	1
4MKN_MRD_A_306	97%	67%	0.068	0.98	0.4	0.85	-	-	0	0	100%	0.5
3GZB_MRD_G_156	96%	70%	0.066	0.973	0.43	0.73	-	-	0	0	100%	1
4YZA_MRD_A_208	94%	59%	0.067	0.965	0.37	1.18	-	1	0	0	100%	0.91

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.